Scientists develop a breath test that could detect stomach cancers

March 6, 2013
Scientists develop a breath test that could detect stomach cancers

A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study published in the British Journal of Cancer.

Scientists from Israel and China took breath samples from 130 patients with a range of different stomach complaints as well as those with stomach cancers.

They found that nanomaterial sensors had over a 90 per cent success rate at differentiating between stomach cancers and more benign conditions. The nanomaterial sensors were also more than 90 per cent accurate at detecting the difference between early and late stage gastric cancers.

The sensors detect biomarkers – a chemical profile that is associated with specific stomach complaints or – in the air people exhaled.

The researchers hope the breath test could be used as an alternative to endoscopies, an accurate but more that is used to diagnose gastric cancers.

Professor Hossam Haick, lead researcher from the Technion - Israel Institute of Technology, said: "The promising findings from this early study suggest that using a breath test to diagnose stomach cancers, as well as more benign complaints, could be a future alternative to endoscopies – which can be costly and time consuming, as well as unpleasant to the patient.

"Nevertheless, these results are at an early stage and support the concept of a breath test to detect stomach cancers but further validations are needed. Indeed, we're already building on the success of this study with a larger-scale clinical trial.

"Around 7,000 people develop in the UK each year and most of these are in their advanced stages when they are diagnosed. But if found to be accurate enough the nanomaterial presents a new possibility for screening a population for stomach cancer, which would hopefully lead to earlier diagnosis of the disease."

Kate Law, director of at Cancer Research UK, said: "The results of this latest study are promising – although large scale trials will now be needed to confirm these findings.

"Only 1 in 5 people are able to have surgery as part of their treatment as most stomach cancers are diagnosed at stages that are too advanced for surgery. Any test that could help diagnose stomach cancers earlier would make a difference to patients' long-term survival."

Explore further: Simple test could hold key to early diagnosis of cancers

More information: Xu, Z. et al. A Nanomaterial-based breath Test for Distinguishing Gastric Cancer from Benign Gastric Conditions (2013) British Journal of Cancer. DOI: 10.1038/bjc.2013.44

Related Stories

Simple test could hold key to early diagnosis of cancers

June 9, 2011
Cancers of the gut, stomach and pancreas could be detected much sooner with a simple urine test, research suggests.

Israeli engineers build artificial device capable of detecting cancer in breath

April 21, 2011
(PhysOrg.com) -- Professor Hossam Haick of the Israel Institute of Technology, at Technion, and his team have built an artificial nose which is capable of detecting molecules in human breath that signal the presence of head ...

Docetaxel significantly increases survival for incurable gastric cancers

January 23, 2013
Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the ...

AIDS patients face risk for esophageal, stomach cancers

September 24, 2012
People with AIDS are at increased risk for developing esophageal and stomach carcinoma as well as non-Hodgkin lymphomas (NHLs), according to a new study in Gastroenterology, the official journal of the American Gastroenterological ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.